Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06767540 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis

Name: A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis — clinical trial record (NCT06767540)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 3

SponsorAkeso

Started2025-01-23

View on ClinicalTrials.gov ↗

Akeso

96 trials monitored

See 1 trial at risk

Atopic Dermatitis

489 trials monitored

See 14 trials at risk

This is a randomized double-blind, placebo-controlled, multicenter phase III clinical study evaluating the efficacy and safety of AK120 in the treatment of moderate-to-severe AD in adolescents.

Trial Details

NCT Number	NCT06767540
Lead Sponsor	Akeso
Conditions	Atopic Dermatitis
Enrollment	198 participants
Start Date	2025-01-23
Primary Completion	2027-07-10 (estimated)
Study Completion	2027-07-10 (estimated)
Updated on ClinicalTrials.gov	2025-01-10